ArticleJournal of family medicine and primary care2026
The practice of family pharmacists in managing polypharmacy for home-based elderly patients.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Family Pharmaceutical Care (FPC) provides personalized, continuous pharmaceutical interventions and health education, creating a home-centered polypharmacy management framework for elderly patients under the supervision of family pharmacists. This study evaluates FPC's feasibility and impact, offering evidence for regional family pharmacist team building and care model development. Methods: This cohort study enrolled 123 elderly patients discharged between January 2024 and March 2025, divided per patient preference into control and observation groups, both for 6months. Quarterly follow-ups assessed clinical outcomes and implementation barriers. Results: Using FPC achieved a net reduction in pharmaceutical expenditures of USD2,002.49 (RMB14,362.06) and demonstrated significantly lower hospitalization costs USD19,704.92 (RMB 141,325.80), and a 17.56% decrease in hospitalization frequency during the 6-month follow-up period compared to controls. The observation group achieved sustained glucose control (FPG 13%, 2hPG 17%, Conclusion: Combining FPC and pharmacy outpatient management with medical care is beneficial. Pharmacists can help patients solve their medication problems through standardized service models, reducing hospitalizations and medical expenses, while also improving the blood sugar, blood pressure, and blood lipid indicators of patients with chronic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.